Medtronic, Inc. (MDT) New Price
Equities study analysts at Oppenheimer (NYSE: OPY) boosted their price target on shares of Medtronic, Inc. (NYSE: MDT) from $42.00 to $48.00 within a research observe to investors on Monday. The analysts at present have an “outperform” rating around the stock.
Shares of Medtronic, Inc. opened at 42.24 on Tuesday. Medtronic, Inc. has a 52 week reduced of $30.80 plus a 52 week large of $43.54. The stock’s 50-day moving regular is $40.28 and its 200-day shifting common is $37.83. The business includes a market place cap of $45.170 billion plus a price-to-earnings ratio of 14.07.
Medtronic, Inc. (Medtronic) is really a healthcare technology company. The company is engaged in investigation, style, manufacture and sale of items to alleviate ache, restore health and extend life. It manufactures and sells device-based health-related therapies. It operates in seven segments: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control.
Read more detail at:
